It is currently Wed Sep 17, 2014 10:38 am

News News of Aubagio (teriflunomide)

Site map of Aubagio (teriflunomide) » Forum : Aubagio (teriflunomide)

Aubagio is an oral treatment approved for MS.

MS drugs Lemtrada and Aubagio launched in Ireland

Genzyme's plans to grow its multiple sclerosis business in Europe continued with the launch of two new treatments in the Republic of Ireland.

The company, which serves as the biotech arm of French pharma firm Sanofi, today launched the injectable Lemtrada (alemtuzumab) in the country just weeks after oral multiple sclerosis (MS) treatment Aubagio (teriflunomide) hit the market...... Read More - http://www.ms-uk.org/aubagio
Read more : MS drugs Lemtrada and Aubagio launched in Ireland | Views : 196 | Replies : 0


Does Aubagio help reduce symptoms?? Or mainly relapses??

Hi
Dragging my feet on getting started with Aubagio. It's mental.......I don't want to be sick again.

Does Aubagio help reduce symptoms?? Such as fatigue, spasticity?? Or is the main hope for it to prevent relapses??

Tysabri helped reduce symptoms. Does Aubagio help like that, I guess is what I am asking??

I know this is like a chemo drug. I've had my share of chemo and it's the pits. I REALLY, REALLY don't want ...
Read more : Does Aubagio help reduce symptoms?? Or mainly relapses?? | Views : 554 | Replies : 0


SMC approves Aubagio® (teriflunomide) for use in MS

The Scottish Medicines Consortium approves Aubagio® (teriflunomide) for use in MS

New oral treatment can be offered as an alternative to currently available injectable treatment options.... Read More - http://www.ms-uk.org/aubagio
Read more : SMC approves Aubagio® (teriflunomide) for use in MS | Views : 536 | Replies : 0


MS drug Aubagio wins final approval from NICE

Sanofi’s multiple sclerosis drug Aubagio won final approval from the U.K.’s health-cost agency, allowing access to a market in which it will compete with Novartis AG’s Gilenya.

The National Institute for Health and Care Excellence, or NICE, recommended Aubagio, also known as teriflunomide, as a treatment option for adults with relapsing-remitting multiple sclerosis, the most common form of the disease, it said in a statement today. The decision confirms a preliminary ruling made last month ...
Read more : MS drug Aubagio wins final approval from NICE | Views : 547 | Replies : 0


Aubagio (bad side effects)

Hello everyone,
I`m taking Aubagio since 9 weeks now (beginning november 2013) and I have some of these mentioned bad side effects like infectious diseases or/and diarrhoea. Is there anybody who can tell how long it will last? Only for weeks or months or even longer? I know there are worse things you can get with MS (we all know it well!) but always felling and being sick isn`t really funny either!

Thank you very ...
Read more : Aubagio (bad side effects) | Views : 1744 | Replies : 3


Teriflunomide in MS: Added benefit not proven

Teriflunomide (trade name: Aubagio) has been approved in Germany since August 2013 for adults with relapsing remitting multiple sclerosis. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the appropriate comparator therapy specified by the Federal Joint Committee (G-BA)....... Read More - http://www.ms-uk.org/aubagio
Read more : Teriflunomide in MS: Added benefit not proven | Views : 565 | Replies : 0


NICE recommends new oral MS drug Aubagio

NICE has recommended that the national health service use Sanofi's new multiple sclerosis pill Aubagio, which will be supplied at a discount.

The National Institute for Health and Clinical Excellence (NICE) - the body that decides if drugs should be paid for - said on Friday its final draft guidance recommended Aubagio, or teriflunomide, for adults with relapsing-remitting multiple sclerosis........ Read More - http://www.ms-uk.org/aubagio
Read more : NICE recommends new oral MS drug Aubagio | Views : 7607 | Replies : 0


Oral MS treatment Aubagio® approved for RRMS in Canada

Genzyme, a Sanofi company, announced today that Health Canada has approved Aubagio® (teriflunomide) 14 mg as monotherapy for the treatment of patients with relapsing remitting multiple sclerosis (RRMS) to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability.

"There are many patients who simply cannot tolerate injections and have had no simple, effective, once daily oral medication until now," said Dr. Mark Freedman, Director, Multiple Sclerosis Research Unit and Professor ...
Read more : Oral MS treatment Aubagio® approved for RRMS in Canada | Views : 8243 | Replies : 0


Re: Aubagio

Hi I'm new to the site and I just begin to take Aubagio 3 days ago. So far so good. I'm not experiencing any side effects as of now( thanking God) I left Copaxone because of injection sites I was literally running out of room. In the last MRI 9/24/13 I had a new lesion that has formed. It's located in the posterior right centrum semiovale. Uncertain about medical terms but it doesn't sound good. ...
Read more : Re: Aubagio | Views : 2523 | Replies : 8


Aubagio(R) significantly reduced risk of relapse & lesions

Aubagio(R) significantly reduced risk of new clinical relapse or MRI lesion in MS study

Genzyme, a Sanofi company , announced positive new data from the TOPIC study of its once-daily, oral Aubagio(R) (teriflunomide). These new data, presented today at the 29th Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS), include the following:

-- Aubagio 14 mg significantly reduced the risk of a new clinical relapse or MRI lesion over the ...
Read more : Aubagio(R) significantly reduced risk of relapse & lesions | Views : 871 | Replies : 0


 

Login  •  Register


Statistics

Total posts 219984 • Total topics 22745 • Total members 14350


Contact us | Terms of Service